Steris
Categories
#938
Rank
$20.6B
Marketcap
Ireland
Country
Adrian Vincent Coward (Senior Vice President)
Andrew Xilas (SVP and GM)
Pharma and Life Sciences
Industrial Manufacturing
Summary
STERIS Corporation offers customized infection prevention and contamination control solutions for a variety of environments. With a unique combination of infection protection and contamination control products and services, STERIS Corporation offers customized solutions for a variety of environments.
It offers customers a unique mix of innovative capital equipment products, such as sterilizers and washers, surgical tables, lights and equipment management systems and connectivity solutions such as operating room integration; consumable products such as detergents and gastrointestinal endoscopy accessories, dental instruments and other products
History
1985: Founded as Innovative Medical Technologies in 1985, in Ohio, USA, the company was renamed “Steris” in 1987.
1993: Steris entered into a joint venture with Indianapolis-based Ecomed, Inc., a manufacturer of hazardous waste disposal equipment.
1995: When the acquisition was announced in December, the company's stock dropped 22 percent in a single day. The company's revenues were almost evenly split between capital equipment sales and recurring sales of consumables, such as chemicals and other accessories.
1996: The acquisition, which was completed in May, added some 300 items to Steris' product line.
1997: As anticipated, revenues rose sharply--up to $587.8 million for the fiscal year ending March 31, a 544 percent increase from the previous year's $91.2 million. After a six-month lull, Steris re-entered the acquisitions game mid-year.
1998: In November, the company announced that its shares would begin trading on the New York Stock Exchange.
1999: At the beginning of the year, the company sold more than 16,000 System 1 units to more than 3,700 facilities.
2004: Steris acquired Albert Browne Ltd in September.
2012: Steris acquired US Endoscopy for $270 million.
2014: In October, Steris executed a tax inversion from the United States to the United Kingdom, via an offer made to acquire UK-based Synergy Health for $1.9 billion. The tax inversion was notable as it was the first US inversion post the new rules introduced by the Obama administration to curb US corporations moving their "legal domicile" to reduce their exposure to US corporate taxation.
2015: On June 24, Steris announced the acquisitions of General Econopak for $175 million and Black Diamond Video for $51 million.
2021: In June, Steris acquired Cantel Medical Corporation a provider of infection prevention products and services for endoscopy, dental and dialysis.
Mission
“We help our Customers create a healthier and safer world by providing innovative healthcare and life science products and services around the globe.”
Vision
“To be the leading global provider of products and services that support patient care with an emphasis on infection prevention.”
Key Team
Daniel A. Carestio (Senior Vice President and Chief Operating Officer)
Cary L. Majors (Sr VP N America Com Operations)
David Baker Lewis (Board Member)
Christopher S. Holland (Board Member)
Jacqueline B. Kosecoff (Board Member)
Cynthia L. Feldmann (Board Member)
Mohsen M. Sohi (Chairman)
Daniel A. Carestio (Senior Vice President and Chief Operating Officer)
Nirav R. Shah (Board Member)
Darrin Blackford (Chief Security Officer)
Paul E. Martin (Board Member)
David Baker Lewis (Board Member)
Richard Carroll Breeden (Board Member)
Ed Pollock (Chief Information Security Officer (CISO))
Walter M Rosebrough Jr. (CEO / President)
Christopher S. Holland (Board Member)
Cynthia L. Feldmann (Board Member)
References
https://en.wikipedia.org/wiki/Steris
https://www.zippia.com/steris-careers-39676/
https://www.crunchbase.com/organization/steris-corporation
https://www.steris.com/about/company
https://sec.report/CIK/0000815065
https://companiesmarketcap.com/largest-companies-by-revenue/
https://finance.yahoo.com/quote/STE/
https://www.globaldata.com/company-profile/steris-plc
Adrian Vincent Coward (Senior Vice President)
Andrew Xilas (SVP and GM)
Pharma and Life Sciences
Industrial Manufacturing